Statistics

Total Visits

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor37

Select a period of time:

Number of views in the range

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor26

Views

Views
November 20240
December 20240
January 20255
February 20252
March 202515
April 20253
May 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States4
Lithuania2
Brazil2
Germany1
Spain1
Mexico1
 

Top cities views

Views
Ourilândia do Norte Municipality1
Pasadena1
Piracicaba1
Reynosa1